Economic evaluation of donepezil in moderate to severe Alzheimer disease

被引:0
|
作者
van Hout, HPJ
Bosmans, JE
Stalman, WAB
机构
关键词
D O I
10.1212/WNL.64.7.1320
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1320 / 1320
页数:1
相关论文
共 50 条
  • [1] Economic evaluation of donepezil in moderate to severe Alzheimer disease
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Hux, M
    Xu, Y
    Schwam, EM
    Shah, S
    Mastey, V
    [J]. NEUROLOGY, 2004, 63 (04) : 644 - 650
  • [2] Donepezil benefits patients with moderate to severe Alzheimer's disease
    Watts, Geoff
    [J]. BRITISH MEDICAL JOURNAL, 2012, 344
  • [3] Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
    Howard, Robert
    McShane, Rupert
    Lindesay, James
    Ritchie, Craig
    Baldwin, Ashley
    Barber, Robert
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Hughes, Alan
    Jacoby, Robin
    Jones, Rob
    Jones, Roy
    McKeith, Ian
    Macharouthu, Ajay
    O'Brien, John
    Passmore, Peter
    Sheehan, Bart
    Juszczak, Edmund
    Katona, Cornelius
    Hills, Robert
    Knapp, Martin
    Ballard, Clive
    Brown, Richard
    Banerjee, Sube
    Onions, Caroline
    Griffin, Mary
    Adams, Jessica
    Gray, Richard
    Johnson, Tony
    Bentham, Peter
    Phillips, Patrick
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 893 - 903
  • [4] Improved health outcomes with donepezil in moderate to severe Alzheimer's disease are associated with economic benefits
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Hux, M
    Emir, B
    Subbiah, P
    Mastey, V
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S74 - S75
  • [5] An economic evaluation of donepezil in the treatment of Alzheimer's disease
    Small, GW
    Donohue, JA
    Brooks, RL
    [J]. CLINICAL THERAPEUTICS, 1998, 20 (04) : 838 - 850
  • [6] Donepezil or memantine improved cognitive functioning in moderate-to-severe Alzheimer disease
    Burke, David
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 156 (12) : JC6 - JC10
  • [7] Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
    Martin Farlow
    Felix Veloso
    Margaret Moline
    Jane Yardley
    Elimor Brand-Schieber
    Francesco Bibbiani
    Heng Zou
    Timothy Hsu
    Andrew Satlin
    [J]. BMC Neurology, 11
  • [8] Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
    Farlow, Martin
    Veloso, Felix
    Moline, Margaret
    Yardley, Jane
    Brand-Schieber, Elimor
    Bibbiani, Francesco
    Zou, Heng
    Hsu, Timothy
    Satlin, Andrew
    [J]. BMC NEUROLOGY, 2011, 11
  • [9] Exploratory analysis of the effects of donepezil in moderate and severe Alzheimer's disease patients
    Gauthier, S
    Feldman, H
    Hecker, J
    Vellas, B
    Emir, B
    Subbiah, P
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S72 - S72
  • [10] Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease
    Gauthier, S
    Feldman, H
    Hecker, J
    Vellas, B
    Ames, D
    Subbiah, P
    Whalen, E
    Emir, B
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2002, 14 (04) : 389 - 404